U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H25NO2
Molecular Weight 311.418
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADIPHENINE

SMILES

CCN(CC)CCOC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=JGOAIQNSOGZNBX-UHFFFAOYSA-N
InChI=1S/C20H25NO2/c1-3-21(4-2)15-16-23-20(22)19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,19H,3-4,15-16H2,1-2H3

HIDE SMILES / InChI
Adiphenine is a ternary amino ligand. It is used as a local anesthetic that reduces the frequency of acetylcholine-induced single-channel currents. It was originally introduced as a spasmolytic agent. Adiphenine reduced the muscle tone of the gastrointestinal tract, bile duct and gallbladder, bronchi, bladder. It affects the tone of the muscles of the eye, causing the pupil dilated (mydriasis), increased intraocular pressure, and paralysis of accommodation. Influences on the cardiovascular system, causing tachycardia and improving AV-conduction. Adiphenine side effects are: nausea, vomiting, heartburn, dizziness, headache. Adiphenine has not been widely used clinically.

CNS Activity

Curator's Comment: Known to be CNS penetrant in mice and rats. Human data not available.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Trasentine

Approved Use

Adiphenine is indicated for the treatment of spasms of smooth muscles of the digestive tract, bile ducts, bronchi.
Primary
Trasentine

Approved Use

Unknown
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG



OverviewOther

Other InhibitorOther SubstrateOther Inducer





Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
no [Activation >10 uM]
no [Activation >10 uM]
no [Activation >10 uM]
yes [Activation 5.01187 uM]
yes [Activation 5.01187 uM]
yes [IC50 158.4 uM]
yes [Inhibition 10 uM]
yes [Inhibition 10 uM]
PubMed

PubMed

TitleDatePubMed
Paxil and self-scratching.
2001 Jan
Serotonin and depression: a disconnect between the advertisements and the scientific literature.
2005 Dec
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis.
2007 Dec
Prevalence and predictors of antidepressant use in a cohort of pregnant women.
2007 Sep
Nutritional therapies for mental disorders.
2008 Jan 21
[The anxyolytic effect of mild hypobaric hypoxia in a model of post-traumatic stress disorder in rats].
2008 Jul-Aug
The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms.
2009 Jul
Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs.
2009 Jun 16
Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008.
2009 Sep
Sequestered evidence and the distortion of clinical practice guidelines.
2009 Spring
Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project.
2010
Patents

Sample Use Guides

50-100 mg 2-3-4 times per day. Course of treatment - 3-4 weeks.
Route of Administration: Oral
Adiphenine decreased the frequency of ACh-induced single-channel currents. Adiphenine decreased cluster duration (36-fold at 100 uM x L(-1)). Preincubation with adiphenine did not change amplitude but increased the decay rate (IC(50)= 15 uM x L(-1)).
Name Type Language
ADIPHENINE
HSDB   INN   MART.   MI   WHO-DD  
INN  
Official Name English
2-(DIETHYLAMINO)ETHYL DIPHENYLACETATE
Systematic Name English
ADIPHENINE [MART.]
Common Name English
BENZENEACETIC ACID, .ALPHA.-PHENYL-2-(DIETHYLAMINO)ETHYL ESTER
Common Name English
ADIPHENINE [MI]
Common Name English
Adiphenine [WHO-DD]
Common Name English
ADIPHENINE [HSDB]
Common Name English
adiphenine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29698
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
Code System Code Type Description
MERCK INDEX
m1419
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY Merck Index
FDA UNII
YKG6OR043Q
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
HSDB
3282
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
RXCUI
333
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY RxNorm
PUBCHEM
2031
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
SMS_ID
100000087702
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
WIKIPEDIA
Adiphenine
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID0022561
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
NCI_THESAURUS
C76456
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
MESH
C084829
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-599-0
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
ChEMBL
CHEMBL353846
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
DRUG CENTRAL
94
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
EVMPD
SUB05272MIG
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
INN
2715
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY
CAS
64-95-9
Created by admin on Sat Dec 16 16:55:53 GMT 2023 , Edited by admin on Sat Dec 16 16:55:53 GMT 2023
PRIMARY